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ventricles and died subsequently due to the central 
nervous system infection. 
This report indicates the clinical spectrum of 
disease caused by this pathogen. However, we did not 
encounter in our series cases of pleuropulmonary, 
ophthalmic or amniotic fluid infections, as reported 
by other authors [7-lo]. Ophthalmologic infection 
secondary to surgical procedures has been reported 
as one of the commonest infections caused by this 
organism [9,10]. However, this diagnosis is a difficult 
one, because of the need for relevant deep samples for 
culture (e.g., intraocular lenses); in our series a few such 
specimens were processed and it is probable that this 
infection could have been missed in a retrospective 
investigation. 
Foreign bodies and previous surgery play 
important roles in the pathogenesis of infection due to 
l? acnes, as shown in this report. The high concentrations 
of l? acnes in the sebaceous glands of the scalp and 
forehead make neurologic sites a target for its patho- 
genic potential [2]. Perhaps for this reason, in 26 of 44 
cases (59.1%) the infection had been detected in a 
neurologic setting. The clinical presentation of these 
infections due to I? acnes (brain abscess, surgical wound 
infection, epidural or subdural empyema) did not differ 
from that of the same diseases caused by other 
organisms. However, in some cases, the course of I? 
acnes infection in the central nervous system may be 
insidious and features may become evident later [4]. 
I? acnes is susceptible to p-lactam antibiotics, 
macrolides and lincosamides but resistant to imidazoles 
[ll]. Antimicrobial therapy was important in the 
therapy of the patients in our series. However, surgical 
procedures seem to have been of equally great 
importance in the management of some patients, 
mainly those who had infections that required a mixed 
surgical-medical approach, such as brain abscesses. 
It is important to recognize that I? acnes, especially 
when it appears in pure culture, can be more than 
simply a ‘contaminant’, and adequate clinical and 
microbiological evaluation of each isolate must be made 
in order to decide its true significance. 
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Reinfection with Mycdacterium tuberculosis in an urban 
tuberculosis hospital 
Clin Microbiol Infect 1998; 4: 49-51 
We report on the reinfection with susceptible Myco- 
bacterium tuberculosis strains in patients in King George 
V Hospital in Durban, KwaZulu-Natal. Twenty-two 
hospitalized patients who remained sputum positive 
after 5 weeks or more of conventional short-course 
antituberculosis chemotherapy (2 months of etham- 
butol, isoniazid, rifampicin and pyrazinamide followed 
by 4 months of three times weekly isoniazid and 
rifampicin) were investigated to determine whether 
they were still infected by the original strain of 
M.  tuberculosis. Pretreatment (PT) and the last positive 
(LP) isolates were fingerprinted by means of IS6210 
restriction fragment length polymorphism (RFLP) 
analysis according to a standard method [l]. RFLPs for 
eight of the 22 patients are shown in Figure 1. 
For 16 patients, RFLPs of paired isolates were 
identical (including one pair in which the LP isolate 
had undergone a single transpositional event). These 
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Figure 1 Lanes 1, 10 and 19 contain the reference strain 
Mt14323. Lane 20 contains a molecular weight marker. 
Paired clinical isolates &om eight of the 22 patients are 
present in lanes 2 and 3, 4 and 5, 6 and 7 (patient 6), 
8 and 9 (patient 4), 11 and 12 (patient l), 13 and 14, 15 
and 16, and 17 and 18, with pretreatment isolates preceding 
the last positive. A discordant RFLP is shown in lane 12 
and is highly similar to that of cluster A shown in lanes 
6-9. Two isolates belonging to cluster B are shown in the 
figure. The isolate in lane 16 did not produce a fingerprint 
and was identified as a MOTT. 
patients are regarded as treatment failures. O f  these 16, 
three clusters containing eight patients were identified, 
indicative of recently acquired infection prior to 
hospitalization. The LP isolate in three of the 22 
patients did not hybridize with IS61 10, and these were 
subsequently identified as mycobacteria other than 
tuberculosis (MOTTS). 
The RFLPs of the LP isolate of the remaining three 
patients were discordant with those of the PT isolates. 
The RFLPs of two of these patients (patients 1 and 2) 
were nearly identical to each other and either identical 
or nearly identical to those belonging to a cluster of 
three (patients 3, 4 and 5). These isolates were fully 
susceptible to antituberculous drugs. The time lapse 
between the paired isolates was 11 and 19 weeks. 
Review of the patients’ records showed an overlap of 
their hospitalization periods as follows: patients 1 and 
2 were hospitalized between 23 March 1994 and 3 June 
1994, and 16 March 1994 and 11 July 1994, respec- 
tively. Patients 4, 5 and 6 were hospitalized between 9 
February 1994 and 24 June 1994, 16 February 1994 
and 19 May 1994, and 21 February 1994 and 27 May 
1994. The second strain ofpatient 1 was isolated on 16 
August 1994 (i.e. at follow-up 10 weeks after discharge) 
and that of patient 2 on 16 June 1994 (during the 
hospitalization period). This means that patient 2 did 
not leave the hospital during the period in which 
reiniection could have occurred. Even though the 
discordant isolate of patient 1 was cultured after 
discharge, the possibility of reinfection having occurred 
from the clustered patients in the hospital is extremely 
high, especially since patient 1 and patient 4 had shared 
a common ward. Patients are not forcibly incarcerated 
in their respective wards for prolonged periods and 
therefore have free contact with one another, thus 
promoting the possibility of reinfection. 
It is highly unlikely that laboratory cross-contarni- 
nation was responsible for these discrepant results, as the 
second strains from both patients were cultured from 
specimens that were received and processed on different 
days from those of the three clustered patients from 
whom they may have acquired infection. Mixed 
infection could possibly explain the discordant RFLPs, 
but our findings that these two patients were hospital- 
ized at the same time as the clustered patients support 
our hypothesis that they were reinfected with a second 
strain of M. tuberculosis while still on treatment during 
hospitalization. 
HIV testing was performed on admission and 2 
months later. Patients 1 and 3 were HIV negative on 
both occasions, and patient 2 was HIV negative at  the 
baseline and with no further serologic data 2 months 
later. Patient 4 tested HIV positive on both occasions 
and patient 5 was negative at the baseline but positive 
at  month 2 (possible ‘window period’). This group of 
five patients is too small to link HIV status with the 
chance of reinfection. However, these patients had 
active TB which, depending on severity, has been 
known to result in impaired immunity which might 
increase susceptibility to reinfection [2,3]. 
The non-matching RFLP of the third patient was 
identical to that of a PT isolate of one of the patients 
whose LP isolate was a MOTT. The lack of overlap in 
their hospitalization periods suggests that these two 
patients were most probably infected by a third patient 
not included in the cohort studied. 
Patients 1, 3 and 5 were reported to be well and 
non-productive at the last visit at 18, 24 and 18 months 
respectively. Patient 2 was reported well at  3 months 
but defaulted at  6 months. Patient 4 was well and 
culture negative at  month 5 but had defaulted there- 
after. After the first readmission between 4 January 
1995 and 8 May 1995, the patient defaulted again and 
was readmitted for the third time between 27 June 1996 
and 18 December 1996. At this point, this patient was 
reported to be well. 
The presence of susceptible strains after prolonged 
periods of treatment is not an unknown phenomenon, 
but is usually related to advanced disease which 
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influences the pharmacokinetics of the drugs adversely. 
This preliminary report of an ongoing study confirms 
the long-held suspicion that reinfection does occur in 
a TB hospital setting in a developing country. What 
is surprising, however, is the transmission of fully 
susceptible strains to patients who are still on therapy. 
It is, therefore, tempting to hypothesize that prolonged 
hospitalization aimed at improving compliance will 
provide the environment for the acquisition of different 
strains by patients on treatment, thereby prolonging the 
time it takes to effect cure. The recently completed TB 
Review by a panel of international experts indicates a 
cure rate of 30-60% in South Africa [4]. The WHO 
has suggested that when cure rates fall below 50%, 
there can be a negative epidemiologic impact on the 
prevalence of smear-positive cases, especially in the 
presence of improved case finding. This is a result of 
increased numbers of chronic transmitters emanating 
fiom therapeutic failures [ 5 ] .  It is hoped that ongoing 
studies in this laboratory will serve to firmly document 
this phenomenon with a view to influencing admission 
policy in hospital settings. 
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Catheter-related bacteremia due to Tsukamurella pulmonis 
Clin Microbiol Infect 1998; 4: 51-53 
Catheter-related bacteremia is an important problem 
for patients with hematologic malignancies in whom 
long-term venous access is required for the safe 
administration of high-dose chemotherapy and optimal 
supportive care. These infections are mainly caused 
by organisms colonizing the skin. Coagulase-negative 
staphylococci and Staphylococcus aureus are the leading 
causes of catheter-related infection. Other reported 
pathogens include Stenotrophomonas maltophilia, Burk- 
holderia cepacia, Corynebacterium sp. and Candida spp. 
Here we report the first case of bacteremia caused by 
Tsukamurella pulmonis; a Hickman catheter-related 
bacteremia in a patient with malignant lymphoma. 
A 38-year-old woman had been well until January 
1995, when she presented with a subacute superior 
vena cava syndrome due to the mediastinal involvement 
of an extended-stage high-grade mahgnant B-cell non- 
Hodgkin’s lymphoma (Burkitt-like). After a brief 
period of radiotherapy and steroids, a Hickman catheter 
was implanted for the administration of several cycles 
of intensive cytoreductive therapy. Remission-induction 
therapy, consisting of daunorubicin, vincristine, cyclo- 
phosphamide, steroids and intrathecal prophylaxis, 
resulted in complete remission. Therapy was completed 
by two consolidation courses and radiotherapy. 
In October 1995 she was readmitted to the hospital 
for autologous peripheral blood progenitor cell trans- 
plantation. Four days before the transplantation, the 
patient developed spiking fever, diarrhea and cramping 
abdominal pain with nausea and vomiting. Because of 
her neutropenic status (l100/mm3), she was started on 
intravenous ceftazidime for a total of 7 days. Repeated 
cultures from blood and stool samples yielded no 
pathogens; chest and abdominal X-ray and ultrasound 
examination were unremarkable. Within the next 2 
